ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

January 30, 2009

NIH Programs: Varmus Appoints 20 To Council of Public Representatives

April 30, 1999

HHS Agency Says It Has No Jurisdiction And No Cause to Act on I-ELCAP Allegations

March 2, 2012

NSABP Protests NIH Rejection Of P-4 Appeal.

May 2, 2008

“Dog And Pony Show” At FCRF For NCAB OFF

April 25, 1980

Genetronics Phase II Trials For Head & Neck Completed.

May 4, 2001